• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Circulating TSH-binding inhibiting immunoglobulins in myasthenia gravis.

作者信息

Kiessling W R, Finke R, Kotulla P, Schleusener H

出版信息

Acta Endocrinol (Copenh). 1982 Sep;101(1):41-6. doi: 10.1530/acta.0.1010041.

DOI:10.1530/acta.0.1010041
PMID:7124292
Abstract

Using a radioligand receptor assay the sera of 46 patients with myasthenia gravis (MG) were tested for the presence of circulating TSH-binding inhibiting immunoglobulins (TBII). In addition thyroid function was evaluated on the basis of T3, T4, TBG and TSH radioimmunoassays including the TRH stimulation test. Circulating antimicrosomal and antithyroglobulin thyroid antibodies were measured by haemagglutination techniques. Two patients had concomitant Graves' disease (GD), 5 were euthyroid with autonomously functioning thyroid tissue due to non-immunogenic multinodular goitre and 39 myasthenic patients were euthyroid with normal pituitary thyroid axis. Only 1 patient with GD had strongly positive TBII-activity and 3 euthyroid MG patients were TBII borderline-positive.

摘要

相似文献

1
Circulating TSH-binding inhibiting immunoglobulins in myasthenia gravis.
Acta Endocrinol (Copenh). 1982 Sep;101(1):41-6. doi: 10.1530/acta.0.1010041.
2
Thyroid function and circulating antithyroid antibodies in myasthenia gravis.重症肌无力患者的甲状腺功能及循环抗甲状腺抗体
Neurology. 1981 Jun;31(6):771-4. doi: 10.1212/wnl.31.6.771.
3
[T3, T4, TSH and circulating antithyroglobulin antibodies in myasthenia gravis].
Endokrinologie. 1981 Oct;78(1):67-72.
4
Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.格雷夫斯病患者甲状腺功能正常的亲属的甲状腺反应,尤其是对促甲状腺素结合抑制性免疫球蛋白的反应:一项临床随访研究
J Clin Endocrinol Metab. 1990 Jul;71(1):210-5. doi: 10.1210/jcem-71-1-210.
5
Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.促甲状腺素受体抗体检测的临床应用:放射受体法与生物测定法的比较
Mayo Clin Proc. 1988 Jul;63(7):707-17. doi: 10.1016/s0025-6196(12)65533-5.
6
Thyrotropin receptor autoantibodies are associated with continued thyrotropin suppression in treated euthyroid Graves' disease patients.促甲状腺素受体自身抗体与接受治疗的甲状腺功能正常的格雷夫斯病患者持续的促甲状腺素抑制有关。
J Clin Endocrinol Metab. 2003 Sep;88(9):4135-8. doi: 10.1210/jc.2003-030430.
7
Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.血清促甲状腺激素(TSH)水平持续受到抑制,可能归因于促甲状腺激素受体抗体活性、甲状腺毒症的严重程度以及接受治疗的甲状腺功能正常的格雷夫斯病患者甲状腺激素恢复所需的时间。
Thyroid. 2006 Dec;16(12):1251-7. doi: 10.1089/thy.2006.16.1251.
8
Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.甲巯咪唑联合或不联合外源性左甲状腺素对格雷夫斯病患者促甲状腺激素(TSH)受体抗体血清浓度的影响。
J Clin Endocrinol Metab. 1996 Sep;81(9):3283-8. doi: 10.1210/jcem.81.9.8784084.
9
[The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].[血清甲状腺自身抗体、碘摄入量与Graves病的发生发展及预后的关系]
Zhonghua Nei Ke Za Zhi. 2006 Feb;45(2):95-9.
10
Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.未经治疗的伴有或不伴有促甲状腺素受体抗体(通过猪甲状腺细胞测定)的格雷夫斯病患者的免疫球蛋白,在培养的人甲状腺滤泡中普遍引发强大的甲状腺激素释放活性。
Thyroid. 1999 Oct;9(10):979-88. doi: 10.1089/thy.1999.9.979.

引用本文的文献

1
Association of TSHR gene single nucleotide intronic polymorphism with the risk of hypothyroid and hyperthyroid disorders in Yazd province.促甲状腺激素受体基因单核苷酸内含子多态性与亚兹德省甲状腺功能减退和甲状腺功能亢进症发病风险的关联。
Sci Rep. 2022 Sep 21;12(1):15745. doi: 10.1038/s41598-022-19822-0.
2
Minimally invasive combined approach robotic thymectomy and transcervical total thyroidectomy.微创联合机器人胸腺切除术和经颈甲状腺全切除术。
BMJ Case Rep. 2022 Apr 22;15(4):e249292. doi: 10.1136/bcr-2022-249292.
3
Concurrence of Myasthenia Gravis and Thyroid Disorders: A Retrospective Database Study.
重症肌无力与甲状腺疾病并存:一项回顾性数据库研究。
J ASEAN Fed Endocr Soc. 2019;34(2):153-157. doi: 10.15605/jafes.034.02.05. Epub 2019 Nov 10.
4
Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.遗传性因素对重症肌无力的影响的流行病学证据:来自北美的回顾性队列研究。
BMJ Open. 2020 Sep 18;10(9):e037909. doi: 10.1136/bmjopen-2020-037909.
5
Management of Thyroid Eye Disease-Related Strabismus.甲状腺眼病相关斜视的管理
J Curr Ophthalmol. 2020 Mar 23;32(1):1-13. doi: 10.1016/j.joco.2019.10.002. eCollection 2020 Jan-Mar.
6
Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.筛查脂蛋白受体相关蛋白4、聚集蛋白和肌联蛋白抗体并探索重症肌无力的自身免疫谱。
J Neurol. 2017 Jun;264(6):1193-1203. doi: 10.1007/s00415-017-8514-z. Epub 2017 May 17.
7
Hypothyroidism, the main thyroid dysfunction in Iranian patients with myasthenia gravis: A case serie.甲状腺功能减退症,伊朗重症肌无力患者的主要甲状腺功能障碍:病例系列
Iran J Neurol. 2011;10(1-2):22-5.
8
Exotropia as a sign of myasthenia gravis in dysthyroid ophthalmopathy.甲状腺功能异常性眼病中,外斜视作为重症肌无力的体征。
Br J Ophthalmol. 1993 Dec;77(12):822-3. doi: 10.1136/bjo.77.12.822.
9
Concomitant euthyroid Graves' ophthalmopathy and isolated ocular myasthenia gravis.伴有甲状腺功能正常的格雷夫斯眼病和孤立性眼肌型重症肌无力
Postgrad Med J. 1990 Oct;66(780):849-52. doi: 10.1136/pgmj.66.780.849.